Limari, April .

HRN: 25-18-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2024
CEFUROXIME 750MG (VIAL)
06/13/2024
06/19/2024
IVT
1.5g Ivt Ld Then 750mg
Q8hrs
Incomplete Abortion
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Dose 

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: